| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,120 | 1,290 | 13:23 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Eco Animal Health Gp - Appointment of Head of Business Development | - | RNS | ||
| 31.03. | Eco Animal Health Gp - Board Change | - | RNS | ||
| 19.03. | IN BRIEF: Eco Animal Health guides improved full-year revenue, margins | 2 | Alliance News | ||
| 19.03. | Eco Animal Health Gp - Full Year Trading Update | - | RNS | ||
| 11.03. | Eco Animal Health's poultry vaccine clears USDA safety review | 1 | Investing.com | ||
| 11.03. | Eco Animal Health erzielt Meilenstein bei US-Zulassung für Geflügelimpfstoff | 1 | Investing.com Deutsch | ||
| ECO ANIMAL HEALTH Aktie jetzt für 0€ handeln | |||||
| 11.03. | Eco Animal Health Gp - ECOVAXXIN MG favourable USDA safety assessment | - | RNS | ||
| 26.02. | Eco Animal Health readies poultry vaccine market entry across the EU | 1 | Alliance News | ||
| 26.02. | ECO Animal Health plans EU rollout for poultry vaccine | 1 | Investing.com | ||
| 26.02. | ECO Animal Health plant EU-weite Markteinführung von Geflügelimpfstoff | 1 | Investing.com Deutsch | ||
| 26.02. | Eco Animal Health Gp - EU launch plans for ECOVAXXIN MS | - | RNS | ||
| 22.12.25 | ECO Animal Health Announces EU Marketing Authorisation For ECOVAXXIN MS | - | RTTNews | ||
| 22.12.25 | Eco Animal Health Gp - ECOVAXXIN MS EU marketing authorisation granted | - | RNS | ||
| 18.12.25 | Eco Animal Health Gp - Exercise of Share Options by Director | - | RNS | ||
| 04.12.25 | Eco Animal Health Gp - Director/PDMR Shareholding | 2 | RNS | ||
| 01.12.25 | Eco Animal Health backs outlook amid upturn in North America and China | 1 | Alliance News | ||
| 01.12.25 | ECO Animal Health Swings To Profit In H1; Stock Up | 1 | RTTNews | ||
| 01.12.25 | Eco Animal Health Gp - Results for the six months ended 30 September 2025 | - | RNS | ||
| 20.11.25 | Eco Animal Health Gp - Replacement: Notice of Results | - | RNS | ||
| 20.11.25 | Eco Animal Health Gp - Notice of Results | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INMODE | 11,810 | -1,46 % | InMode Ltd.: InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million | YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| RYMAN HEALTHCARE | 1,033 | +3,51 % | Ryman Healthcare Achieves FY26 Sales Guidance Amidst Strong Q4 Performance | ||
| TANDEM DIABETES | 17,800 | 0,00 % | Truist upgrades Tandem Diabetes Care stock rating on Pay/Go model | ||
| JD HEALTH INTERNATIONAL | 5,188 | -1,22 % | HSI Weakens on Thinner Turnover; Auto Stocks Rally; JD Health Slumps Over 9% | ||
| RADNET | 49,590 | +1,27 % | RadNet, Inc.: RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA?? and Releases 2026 Financial Guidance | Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable... ► Artikel lesen | |
| STAAR SURGICAL | 21,280 | +2,70 % | Morning Market Movers: Click Holdings, STAAR Surgical, The Simply Good Foods Company, Richardson Electronics See Big Swings | OTTAWA (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| TRANSMEDICS GROUP | 97,46 | -0,67 % | TransMedics Group, Inc.: TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results | ANDOVER, Mass., Feb. 24, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant... ► Artikel lesen | |
| MEDACTA | 162,00 | -2,41 % | Medacta Group SA: Medacta Group SA publishes 2026 Annual General Meeting invitation | Medacta Group SA
/ Schlagwort(e): Generalversammlung/Generalversammlung
Medacta Group SA publishes 2026 Annual General Meeting invitation
07.04.2026 / 10:00 CET/CEST
Press... ► Artikel lesen | |
| DYNAVOX GROUP | 8,150 | -0,18 % | Invitation to Dynavox Group's webcast following the interim report for the first quarter 2026 | ||
| CAREDX | 14,800 | -1,33 % | CareDx (CDNA) Launches AI-based Platform VANTx | ||
| INTERPACE BIOSCIENCES | 1,630 | 0,00 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results | Q4 and FY Revenue of $9.2 million and $38.7 millionQ4 and FY Income from Continuing Operations of $22.8 million and $25.0 million (benefiting from a one-time, non-cash tax-related accounting adjustment)Q4... ► Artikel lesen | |
| AVANOS MEDICAL | 21,400 | +1,90 % | Morning Market Movers: Avanos Medical, Sana Biotechnology, Credo Technology Group, Bloom Energy See Big Swings | BEIJING (dpa-AFX) - At 7:30 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| CHECK-CAP | 1,510 | +1,34 % | Humanoid Global gibt strategische Investition in MBody AI, Entwickler einer Autonomieplattform für verkörperte KI bekannt | - NICHT ZUR VERBREITUNG IN DEN VEREINIGTEN STAATEN ODER ÜBER US-NACHRICHTENDIENSTE BESTIMMT -
Vancouver, BC und Las Vegas, Nevada - 7. Januar 2026 / IRW-Press / Humanoid Global
... ► Artikel lesen | |
| VIVANI MEDICAL | 0,815 | +1,88 % | Vivani Medical, Inc.: Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra long-acting semaglutide implant under... ► Artikel lesen | |
| MICROPORT SCIENTIFIC | 0,975 | -0,51 % | UBS Upgrades MICROPORT MEDBOT to Buy on Strong Overseas Sales, Expects Breakeven in 1H26 |